期刊文献+

铜绿假单胞菌耐药率与抗菌药物使用强度的相关性研究 被引量:7

Antimicrobial resistance rate of Pseudomonas aeruginosa and it's correlation with antimicrobial use density
下载PDF
导出
摘要 了解铜绿假单胞菌耐药率及其与住院患者抗菌药物使用强度(AUD)间的关系,为医院感染控制工作提供参考。方法对2011年7月—2013年12月某医院住院患者分离的铜绿假单胞菌耐药率及同期住院患者AUD进行监测,并对两者进行相关性分析。结果该院住院患者总AUD从2011年第三、四季度的73.61下降至2013年第三、四季度的41.33。住院患者AUD与铜绿假单胞菌耐药率相关性分析,相关系数r为-0.32~0.88,其中铜绿假单胞菌对氨曲南耐药率与氨曲南使用强度相关系数为0.88,其相关性具有统计学意义。结论住院患者AUD下降,铜绿假单胞菌的耐药率呈现下降趋势,提示临床应考虑抗菌药物的选择性筛选耐药。 Objective To realize antimicrobial resistance rate of Pseudomonas aeruginosa (P. aeruginosa) and it's correlation with antimicrobial use density(AUD), and to provide reference for control of healtheare-assoeiated infec- tion. Methods From July 2011 to December 2013, antimicrobial resistance rate of P. aeruginosa isolated from hospi- talized patients and AUD of patients were monitored, and the correlation between them was analyzed. Results AUD of patients decreased from 73.61 in the third and fourth quarters of 2011 to 41.33 in the same quarters of 2013. Corre- lation coefficient of AUD and antimicrohial resistance rate of P. aeruginosa was - 0.32~0.88, correlation coeffi- cient of resistance rate of P. aeruginosa to aztreonam and aztreonam use density was 0.88,there was statistical sig- nificance. Conclusion AUD of hospitalized patients revealed a decreasing tendency, suggesting antimicrobial selec- tive resistance should he considered in clinic.
出处 《中国感染控制杂志》 CAS 2014年第11期646-649,共4页 Chinese Journal of Infection Control
基金 湖北省教育厅科研项目(B20112119) 十堰市科学技术研究与开发项目(2010st16) 湖北医药学院附属太和医院博士科研启动项目
关键词 铜绿假单胞菌 医院感染 抗菌药物 抗药性 微生物 合理用药 Pseudomonas aeruginosa healthcare-associated infection antimicrobial agent drug resistance, microbial rational drug use
  • 相关文献

参考文献7

二级参考文献33

  • 1高美英.抗生素耐药性的起源、传播和对策[J].抗感染药学,2005,2(1):1-3. 被引量:31
  • 2陈敏,尹维佳,周陶友,乔甫,吕晓菊,刘力克.综合性医院抗菌药物应用管理成效[J].中华医院感染学杂志,2007,17(1):71-74. 被引量:39
  • 3张群,席淑华,谢少飞,薛静洁,彭洁洁.普通外科围手术期抗菌药物合理使用的干预对照研究[J].中国感染控制杂志,2007,6(4):247-249. 被引量:33
  • 4Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosoeomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309- 317.
  • 5Bouza E, San Juan R, Munoz P,etal. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection[J]. Clin Microbio Infect, 2001,7(10) : 532-542.
  • 6HidronAI, Edwards JR, Patel J,et al.Antimicrobial resistant pathogens associated healthcare-associated infections: annual summary of date reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J].Infect Control Hosp Epidemiol, 2008, 29 (11) :996-1011.
  • 7罗少锋,彭少华,顾剑.湖北地区金黄色葡萄球菌耐药性变迁[J].中华医院感染学杂志,2007,17(8):996-997. 被引量:14
  • 8Taherikalani M, Fatolahzadeh B, Emaneini M, et al. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals[J]. New Microbiol, 2009,32 (3):265-271.
  • 9MacLeod DL, Barker LM, Sutherland JL,et al. Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis[J]. J Antirnicrob Chemother, 2009,64(4) : 829-36.
  • 10Sader H S,Moet G J,Jones R N.Antimicrobial resistanceamong gram-positive bacteria isolated in Latin American hospi-tal[J].J Chemother,2009,21(6):611-620.

共引文献457

同被引文献71

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部